Please assess the completion status of the following clinical trial:

Trial Title: Aspirin and Enoxaparin for VTE in Trauma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 years or older~* Blunt or penetrating trauma~* Requires VTE thromboprophylaxis~* High-risk for VTE~Exclusion Criteria:~* Presence of VTE upon admission~* Pregnant or nursing~* Inability to give informed consent by patient or healthcare proxy~* Contraindication to enoxaparin~* Contraindication to aspirin~* Epidural or subdural hematoma~* Presence, or removal within the last 12 hours, of an epidural or spinal catheter, or recent (within the last 12 hours) epidural or spinal anesthesia/procedures

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Low Molecular Weight Heparin (LMWH) + Aspirin (ASA) (Type: EXPERIMENTAL): Group will get both enoxaparin (standard of care) and aspirin (intervention) after consent up to Intensive Care Unit (ICU) discharge.
- Low Molecular Weight Heparin (LMWH) Alone (Type: ACTIVE_COMPARATOR): Group will get only enoxaparin (standard of care) after consent up to Intensive Care Unit (ICU) discharge.

Based on this trial design, predict the completion outcome and termination type (if applicable).